Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil

BACKGROUND AND OBJECTIVES: Malignant hyperthermia is an autosomal dominant hypermetabolic pharmacogenetic syndrome, with a mortality rate of 10%–20%, which is triggered by the use of halogenated inhaled anesthetics or muscle relaxant succinylcholine. The gold standard for suspected susceptibility to...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Helga Cristina Almeida da, Ferreira, Gisele, Rodrigues, Gislene, Santos, Joilson Moura dos, Andrade, Pamela Vieira, Hortense, Alexandre, Perez, Marcelo Vaz, Amaral, José Luiz Gomes do
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391845/
https://www.ncbi.nlm.nih.gov/pubmed/30935497
http://dx.doi.org/10.1016/j.bjane.2018.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391845/
https://www.ncbi.nlm.nih.gov/pubmed/30935497
http://dx.doi.org/10.1016/j.bjane.2018.09.009

Ejemplares similares